Boston Scientific Acquires Vertiflex from H.I.G. BioHealth Partners

June 18, 2019

Boston Scientific acquired Vertiflex, Inc., a Carlsbad-based developer of the Superion interspinous spacer for lumbar spinal stenosis, for approximately $465 million in cash plus contingent payments. The transaction was announced in May 2019 and completed in June 2019; Vertiflex had been backed by H.I.G. BioHealth Partners.

Buyers
Boston Scientific
Targets
Vertiflex, Inc.
Sellers
H.I.G. BioHealth Partners
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.